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Abstract
Background: Acquired toxoplasmosis more frequently goes unrecognized. Immunocompetent
adults and adolescents with primary infection are generally asymptomatic, but symptoms may
include malaise, fever, and lymphadenopathy. By contrast, immunocompromised patients may
experience severe manifestations including encephalitis and multisystem organ failure.
Case presentation: We report a case of polymyositis and myocarditis in a 13-year old
immunocompetent girl with toxoplasmosis. The patient presented with proximal muscle weakness,
dysphagia, palms and soles rash and elevated serum levels of muscle enzymes, with liver and
myocardial involvement. The diagnosis of toxoplasmosis was confirmed by serology. The patient
was treated with prednisolone and had an excellent outcome. During a follow-up period of four
years no relapses occurred and antibody levels to the T. gondii significantly decreased.
Conclusions: Although several previous cases of toxoplasmosis occuring in association with
polymyositis have been described in the literature such a wide spectrum of acute toxoplasmosis is
rather unusual in immunocompetent adolescents. The relationship between T. gondii and
polymyositis remains obscure. Appropriate investigation should be performed in every case of
polymyositis not only for the appropriate treatment but also for further elucidation of this
relationship.
Background
Toxoplasma gondii is the most common cause of proto-
zoan infections in humans. Cats are the definitive hosts
which produce oocysts and sporozoites. Ingestion by a
nonfeline leads to the formation of tachyzoites and fur-
ther dissemination with the formation of cysts in skeletal
muscle, heart muscle and central nervous system (CNS).
The acquired disease can be transmitted in humans by
ingestion of tissue cysts in inadequately cooked meat or
by ingestion of uncooked food that have come in contact
with contaminated meat. The infection is usually asymp-
tomatic, however clinical manifestations do occur, rang-
ing from mild, nonspecific febrile illness and
lymphadenopathy to systemic disease in immunocom-
promised patients [1–3]. The severe form of the disease
may present with muscle, heart, liver and central nerv-
ous system involvement. Significant organ involvement
in immunocompetent individuals is uncommon but
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some individuals have suffered significant morbidity
[1,2].
Acquired toxoplasmosis has been associated with polyo-
myositis and myocarditis but it remains obscure whether
this is a causal of coincidental relationship [4]. We report
a case of myocarditis and polyomyositis associated with
acquired toxoplasmosis in an otherwise well adolescent.
Case Presentation
A previous healthy 13-year-old Caucasian girl was admit-
ted with a 3-week history of vomiting, daily fever up to
38,9°C, malaise, anorexia and a 3-kilogram weight loss.
The history was unremarkable for tick exposure or for re-
cent travel. On physical examination axillary tempera-
ture was 38,2°C, the systolic blood pressure 110 mmHg,
and the pulse rate 120 beats per min. Her liver was ten-
der and palpable 3 cm subcostally. A mild proximal mus-
cle weakness was noted.
Laboratory investigation revealed hemoglobin; 10.6 g/
dl, total leukocyte count; 4,600/mm3, neutrophils;
2,300/mm3, lymphocytes; 1610/mm3, monocytes; 460/
mm3, band forms; 230/mm3, and adequate platelets.
The erythrocyte sedimentation rate was 45 mm/h and
the C reactive protein 0.5 mg/dl. Total serum protein, al-
bumin and globulin concentrations were slightly de-
creased. Elevated serum values were found for alanine
aminotransferase (407 IU/L), aspartate aminotrans-
ferase (639 IU/L), gamma-glutamyltranspeptidase (120
IU/L), lactate dehydrogenase (478 IU/L), creatine ki-
nase (407 IU/L) and aldolase (16,9 IU/L). Urinalysis and
clotting studies were normal. No pathogens were detect-
ed in urine, stool and blood cultures. A Mantoux tuber-
culin test was negative. Abdominal ultrasonography
revealed a round, not cystic liver lesion of a diameter of 2
cm. This finding was confirmed by abdominal computed
tomography.
With a presumptive diagnosis of a bacterial liver abscess,
intravenous ampicillin, amikacin and metronidazole
were initiated. In the following days the patient dramat-
ically deteriorated, with dysphagia, inability to walk and
raise the arms, further weight loss, fine tremor of hands
and a maculopapular rash on palms and soles. Visual
symptoms suggestive of chorioretinitis were not found.
At that stage creatine kinase, lactate dehydrogenase and
aldolase levels reached to peak values of 607 IU/L, 935
IU/L and 43 IU/L respectively. Alpha-fetoprotein, urine
vanilmandelic acid and liver Tc-99 scan were normal. Se-
rology for Salmonella typhi, Brucella melitensis, Myco-
plasma pneumonia, Echinococcus granulosus,
Trichinella spiralis, Coxsackie, herpes and hepatitis vi-
ruses was negative. Toxoplasmosis was serologically
confirmed by a serial two tube tenfold increase of anti-
body titer by haemagglutination test (titer of 1:150 for
IgM and 1:1024 for IgG and four weeks later titer of 1:150
for IgM and IgG: 1:109,350). Electromyogram was com-
patible with subacute inflammatory myopathy with brief
polyphasic motor units of decreased amplitude as well as
a few fibrillations during the voluntary contraction of the
muscle. Echocardiogram showed dilatation of the left
ventricle with poor contractility, suggestive of myocar-
dial involvement. Antinuclear, anti-DNA, anti-Jo-1, anti-
RNP and ANCA antibodies were negative. Serum IgG
was 1,771 mg/dl, IgA 229 mg/dl and IgM 195 mg/dl.
Complement C3 and C4 serum levels were normal.
Given the clinical and laboratory evidence of ongoing in-
flammation, and the heart involvement, intravenous
prednisolone at a dose of 1,2 mg/kg daily, captopril at a
dose of 25 mg twice daily, digoxin at a dose of 0.25 mg
once daily were administered. Naproxen was added at a
dosage of 750 mg daily a week later. The response to ster-
oids was favorable. Fever subsided within two weeks and
clinical and laboratory findings gradually improved.
Steroid dosage was tapered to 1 mg/kg at discharge and
treatment was continued with digoxin and captopril. Di-
goxin and captopril were continued until the normaliza-
tion of echocardiogram two months later. Steroids and
naproxen were weaned over a period of five and twelve
months respectively. The rash on palms and soles sub-
sided within three months and the liver lesion was no
longer visible eighteen months after admission. T. gondii
IgM serology converted to negative twelve months,
whereas IgG antibodies remained at high levels (>
1:100,000) for eighteen months with a gradual decrease
thereafter. A four-year follow up period was free of any
symptoms or findings.
Discussion
Inflammatory muscle disease in children may be consid-
ered either acute or chronic. Most of acute inflammatory
myopathies are usually associated with viral or bacterial
infectious agents [4–6]. Chronic idiopathic myopathies
comprise a diverse group of syndromes that have a com-
mon chronic muscle inflammation of usually unknown
pathophysiology [5]. Skeletal muscle can be the site of in-
flammatory diseases that lead to muscle weakness, pain
and increased myogenic enzymes [4,7].
Many bacterial, viral and parasitic pathogens can cause
acute transient inflammatory myopathies, including Sta-
phylococci, Mycoplasmas, Coxsackie group B and influ-
entza viruses, trichinosis, toxoplasmosis, and
cysticercosis [4–6,8]. Recent studies suggest that acute
infectious polymyositis has a different course than the
idiopathic one [4,5].BMC Musculoskeletal Disorders 2001, 2:8 http://www.biomedcentral.com/1471-2474/2/8
The major symptom of chronic inflammatory myopathy
in children is persistent and progressive proximal mus-
cle weakness. Diagnostic criteria proposed by Bohan and
Peter in 1975 are still used to establish the diagnosis of
polymyositis in childhood (Table 1) [5,9]. The described
case fulfilled two out of four polymyositis diagnostic cri-
teria: Symmetrical proximal muscle weakness and ele-
vated muscle derived enzymes. The electromyographic
pattern was not typical for acute inflammation, however
it was clearly abnormal and suggestive of subacute in-
flammatory process, hence it was considered as the third
criterion. Muscle histopathology was not performed in
the present case because of the patient's severe deterio-
ration and the administration of prednisolone which
could interfere with the results of the biopsy.
Toxoplasmosis may affect muscles, during either prima-
ry infection or reactivation and even cause multisystem
disease, mainly in immunocompromised individuals
[4,10]. Two forms of polymyositis following toxoplasmo-
sis are known; an acute, responsive to antiprotozoal
therapy and a chronic manifested by altered immune re-
sponse and requiring treatment with steroids [10].
In our patient acute T. gondii infection was confirmed by
both the presence of IgM and the rising titers of IgG an-
tibodies [4]. Hence, it is likely that T. gondii directly
caused the acute myositis and myocarditis. PCR for T.
gondii was not available at that time. The liver lesion
might be attributed to toxoplasmosis as well, since he-
patic necrosis is a well-established complication of this
infection. The impressive improvement following treat-
ment with prednisolone was suggestive of immunologi-
cal disturbances contributing to the development of
inflammatory myositis. The presence of parasite in my-
ofibers would be not enough to induce an inflammatory
myositis with muscle cell necrosis. A potential mecha-
nism for polymyositis might include an altered immune
response leading to the production of autoantibodies and
to muscular inflammation [4,7,10]. After the initial favo-
rable response to steroids antiprotozoal agents were not
considered as adjunct therapy.
We propose that polymyositis due to toxoplasmosis has
two phases: an early one, usually self-limited and re-
sponsive to antiprotozoal therapy and a late one mani-
fested by altered immune response requiring steroids.
Clinical manifestations of late toxoplasmosis myositis
may mimic those of idiopathic polymyositis, however the
clinical course in immunocompetent patients is usually
benign because of the generation of antibodies which will
inhibit the growth of organism [10].
The complete recovery of the patient and the absence of
any relapses suggest a recent toxoplasmic rather than a
chronic idiopathic polymyosistis. Although such a wide
spectrum of acute toxoplasmosis is not common in im-
munocompetent patients, several previous cases of toxo-
plasmosis in association with polymyositis have been
described in the literature [10–13]. The presence of both
polymyositis and myocarditis in the same patient with
toxoplasmosis is uncommon and has been reported in
autopsy and in a few cases in adults [14]. In patients with
myocarditis, asymptomatic conduction abnormalities
predominate with occasional complete right bundle
block. These abnormalities often resolve with abatement
of the disease activity [5]. Although the patient's Toxo-
plasma serology was consistent with acute infection, en-
domyocardial and skeletal biopsies might establish the
definitive diagnosis of toxoplasmic myocarditis or my-
ositis respectively [4,7,12,14,15].
In conclusion every case with polyomyositis and myocar-
ditis should be investigated for toxoplasmosis. Although
appropriate therapy may provide some clinical improve-
ment at the early stages of acute toxoplasmosis, steroids
seems to remain the cornerstone of management, espe-
cially when vital organ involvement is implicated
[8,10,11].
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